Clinical Trials Logo
  1. Home
  2. Otitis Media
  3. NCT01611246
  4. Details
NCT01611246 Clinical Trial

Earset Healthy Volunteer Study

Otitis Media Clinical Trial

Official title:
Performance of the Acclarent Iontophoresis System With Earset (IPSES) in Healthy Volunteers

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT01611246
Other study ID # CPR005031
Secondary ID
Status Completed
Phase N/A
First received May 29, 2012
Last updated July 21, 2017
Start date May 1, 2012
Est. completion date August 1, 2012

Study information
Verified date July 2017
Source Acclarent
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The study will recruit healthy volunteers to undergo the Iontophoresis procedure using the Acclarent Iontophoresis System with Earset (IPSES).

Recruitment information / eligibility
Status Completed
Enrollment 22
Est. completion date August 1, 2012
Est. primary completion date August 1, 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 12 Months and older
Eligibility Inclusion Criteria:

- At least 12 months old

Exclusion Criteria:

- Pregnant or lactating females

- Subjects with history of sensitivity or reaction to lidocaine, tetracaine, epinephrine, or any hypersensitivity to local anesthetics of the amide type, or any component of the drug solution

- Significantly atrophic or perforated tympanic membrane

- Otitis externa

- Damaged or denuded skin in the auditory canal

- Electrically sensitive subjects and subjects with electrically sensitive support systems (pacemakers, defibrillators, etc.)

- Cerumen impaction resulting in a significant amount of cleaning required to visualize the tympanic membrane

- Evidence of Otitis Media at day of procedure, or within the past three (3) months prior to procedure.

Study Design

Related Conditions & MeSH terms

Intervention

Device:
• Iontophoresis System With Earset
iontophoresis of lidocaine-based solution for numbing tympanic membrane

Locations
Country Name City State
United States CEI Medical Group East Palo Alto California

Sponsors (1)
Lead Sponsor Collaborator
Acclarent

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Number of subjects anesthetized as assessed by Wong-Baker scale Day 1
Secondary Number of participants with serious adverse events Day 1
See also
  Status Clinical Trial Phase
Completed NCT04016051 - Acceptance of Clarithromycin in a Straw Compared to Syrup in Children With Upper Respiratory Tract Infections Phase 3
Completed NCT02452164 - Family MobilePhone Otoscopy in Diagnostics of Otitis Media N/A
Completed NCT01199016 - Effect of Prevnar 13 on Ear Infections in Children Phase 4
Terminated NCT00778063 - Study Using Dexmedetomidine to Decreases Emergence Delirium in Pediatric Patients N/A
Completed NCT00195611 - Study of Streptococcus Pneumoniae in Nose and Throats of Infants With Acute Otitis Media Phase 4
Recruiting NCT03722160 - Clinical Study of the Solo Tympanostomy Tube Device N/A
Recruiting NCT04447521 - Surveillance of Non-invasive Streptococcus Pneumoniae Infections in Belgium
Active, not recruiting NCT05127161 - Broad Implementation of Outpatient Stewardship N/A
Completed NCT02600559 - Open-Label Study of OTO-201 in Pediatric Subjects With a History of Otitis Media Requiring Tympanostomy Tubes Phase 3
Completed NCT01444391 - inVENT-visIOn Study N/A
Enrolling by invitation NCT01437436 - The Effect of Obesity on Ventilation Tube Insertion N/A
Completed NCT01003210 - Homeopathic Ear Drops for Otitis Media Study N/A
Completed NCT00768534 - Study Evaluating Microbiological Analysis of Spontaneous Draining Acute Otitis Media N/A
Recruiting NCT00393159 - The Influence of The Ear Popper on Serous Otitis Media and on the Accompanying Conductive Hearing Loss in Children Phase 4
Completed NCT00617682 - Maternal Immunization To Prevent Infant Otitis Media Phase 1/Phase 2
Withdrawn NCT00956748 - N-Acetylcysteine as an Adjunct for Refractory Chronic Suppurative Otitis Media Phase 4
Withdrawn NCT01908764 - Pharmacokinetic Study of AL-60371 Otic Suspension in Pediatric Subjects Following Tympanostomy Tube Surgery Phase 1
Recruiting NCT01619462 - Safety and Immunogenicity of 10-valent and 13-valent Pneumococcal Conjugate Vaccines in Papua New Guinean Children Phase 3
Completed NCT02616458 - The Impact of Ear Pain Anticipatory Guidance Counseling on Otitis Related Visits in a Low Income Population N/A
Completed NCT00051753 - Levofloxacin In The Treatment Of Children With Recurrent And/or Persistent Acute Otitis Media Phase 3